Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995490361> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W1995490361 endingPage "8156" @default.
- W1995490361 startingPage "8150" @default.
- W1995490361 abstract "RCL is a c-Myc target with tumorigenic potential. Genome annotation predicted that RCL belonged to the N-deoxyribosyltransferase family. However, its putative relationship to this class of enzymes did not lead to its precise biochemical function. The purified native or N-terminal His-tagged recombinant rat RCL protein expressed in Escherichia coli exhibits the same enzyme activity, deoxynucleoside 5′-monophosphate N-glycosidase, never before described. dGMP appears to be the best substrate. RCL opens a new route in the nucleotide catabolic pathways by cleaving the N-glycosidic bond of deoxynucleoside 5′-monophosphates to yield two reaction products, deoxyribose 5-phosphate and purine or pyrimidine base. Biochemical studies show marked differences in the terms of the structure and catalytic mechanism between RCL and of its closest enzyme family neighbor, N-deoxyribosyltransferase. The reaction products of this novel enzyme activity have been implicated in purine or pyrimidine salvage, glycolysis, and angiogenesis, and hence are all highly relevant for tumorigenesis. RCL is a c-Myc target with tumorigenic potential. Genome annotation predicted that RCL belonged to the N-deoxyribosyltransferase family. However, its putative relationship to this class of enzymes did not lead to its precise biochemical function. The purified native or N-terminal His-tagged recombinant rat RCL protein expressed in Escherichia coli exhibits the same enzyme activity, deoxynucleoside 5′-monophosphate N-glycosidase, never before described. dGMP appears to be the best substrate. RCL opens a new route in the nucleotide catabolic pathways by cleaving the N-glycosidic bond of deoxynucleoside 5′-monophosphates to yield two reaction products, deoxyribose 5-phosphate and purine or pyrimidine base. Biochemical studies show marked differences in the terms of the structure and catalytic mechanism between RCL and of its closest enzyme family neighbor, N-deoxyribosyltransferase. The reaction products of this novel enzyme activity have been implicated in purine or pyrimidine salvage, glycolysis, and angiogenesis, and hence are all highly relevant for tumorigenesis. The c-Myc transcription factor plays an important role in the regulation of the cell cycle, cellular transformation, and apoptosis (1Eisenman R.N. Genes Dev. 2001; 15: 2023-2030Crossref PubMed Scopus (320) Google Scholar) as well as in the genesis of many human cancers (2Nesbit C.E. Tersak J.M. Prochownik E.V. Oncogene. 1999; 18: 3004-3016Crossref PubMed Scopus (957) Google Scholar). The deregulation of MYC expression by chromosomal translocation, amplification, or altered signal transduction is commonly found in human cancers (3Escot C. Theillet C. Lidereau R. Spyratos F. Champeme M.H. Gest J. Callahan R. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 4834-4838Crossref PubMed Scopus (357) Google Scholar, 4Little C.D. Nau M.M. Carney D.N. Gazdar A.F. Minna J.D. Nature. 1983; 306: 194-196Crossref PubMed Scopus (641) Google Scholar). To elucidate the mechanisms by which c-Myc contributes to tumorigenesis, several approaches have been used to identify its target genes, which are compiled in the data base myccancergene.org.Rcl was identified as a c-Myc target by representational difference analysis between non-adherent Rat1a fibroblasts and Rat 1a cells transformed by MYC (5Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (131) Google Scholar). Rcl is expressed at a low level in untransformed cell lines, although it is significantly elevated in breast cancer and lymphoma cell lines (5Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (131) Google Scholar). Moreover, Rcl is one of the most responsive targets to Myc activation in vitro and in Myc-induced transgenic lymphoma (6Kim S.Y. Herbst A. Tworkowski K.A. Salghetti S.E. Tansey W.P. Mol. Cell. 2003; 11: 1177-1188Abstract Full Text Full Text PDF PubMed Scopus (419) Google Scholar, 7Keller U. Nilsson J.A. Maclean K.H. Old J.B. Cleveland J.L. Oncogene. 2005; 24: 6231-6240Crossref PubMed Scopus (32) Google Scholar), and Rcl has been shown to be a direct Myc target in a human lymphoma cell model (8Zeller K.I. Jegga A.G. Aronow B.J. O'Donnell K.A. Dang C.V. Genome Biol. 2003; 4: R69Crossref PubMed Google Scholar). Serial analysis of gene expression studies revealed that Rcl is also highly expressed in human glioblastoma multiforme as compared with normal human brain (information from the UniGene data base, at NCBI). Furthermore, Rcl is among the top 50 genes whose overexpression distinguishes between benign and malignant prostate tissues (9Rhodes D.R. Barrette T.R. Rubin M.A. Ghosh D. Chinnaiyan A.M. Cancer Res. 2002; 62: 4427-4433PubMed Google Scholar). Functionally, Rcl has transforming activity in Rat1a cells when coexpressed with either vascular endothelial growth factor or lactate dehydrogenase (10Lewis B.C. Prescott J.E. Campbell S.E. Shim H. Orlowski R.Z. Dang C.V. Cancer Res. 2000; 60: 6178-6183PubMed Google Scholar). Altogether, these data suggest that RCL could be a prime therapeutic target.RCL appears to be a nuclear 22-kDa protein with yet unknown function. The closest relatives of RCL protein are members of the nucleoside 2-deoxyribosyltransferase family (EC 2.4.2.6). (pfam 05014), which catalyze the reversible transfer of the deoxyribosyl moiety from a deoxynucleoside donor to an acceptor nucleobase (11Macnutt W.S. Biochem. J. 1952; 50: 384-397Crossref PubMed Scopus (72) Google Scholar, 12Uerkvitz W. Eur. J. Biochem. 1971; 23: 387-395Crossref PubMed Scopus (22) Google Scholar, 13Holguin-Hueso J. Cardinaud R. FEBS Lett. 1972; 20: 171-173Crossref PubMed Scopus (21) Google Scholar). Here, we report the purification and characterization of the recombinant RCL from rat. RCL is a deoxynucleoside 5′-monophosphate N-glycosidase, an enzyme never described before. Its putative role in the mammalian nucleotide metabolism and tumorigenesis is also discussed.EXPERIMENTAL PROCEDURESChemicals—Ribonucleosides and deoxyribonucleosides, mono-, di-, and triphosphate derivatives of adenine, cytosine, guanine, hypoxanthine, thymine, and uracil were from Sigma-Aldrich. 6-Methylthio-guanosine 5′-monophosphate, 2′-deoxyguanosine 3′-monophosphate, and 8-oxo-deoxyguanosine 5′-monophosphate were from Jena Bioscience.Overexpression and Purification of RCL and of the N-terminal His-tagged RCL—The Rcl cDNA cloned into pCR2.1 as a NcoI-BamHI fragment was subcloned into pET24d digested with the same restriction enzymes. The resulting pET24dRcl was used to transform strain Bli5 (BL21 (DE3) pDIA17). One liter of LB medium supplemented with 50 μg/ml of chloram-phenicol and kanamycin was inoculated with an overnight culture of Bli5 containing pET24dRcl. The culture was grown under agitation at 37 °C until an A600 of 0.8. Isopropyl-1-thio-β-d-galactopyranoside was added to a final concentration of 1 mm and the cultures further incubated for 3 h. Bacteria were harvested by centrifugation at 4500 × g for 20 min at 4 °C and the pellet frozen at -20 °C. The cells were resuspended in 35 ml of 50 mm Tris, pH 7.5, and broken by two passages through a French press at 14,000 pounds/square inch. The lysate was centrifuged at 25,000 × g for 30 min at 4 °C. The supernatant was loaded on a Q-fast flow column previously equilibrated with the same buffer. Proteins were eluted with a 0–40% NaCl gradient. RCL was eluted between 20 and 25% NaCl, and the corresponding fractions were pooled and precipitated with solid ammonium sulfate. Pelleted RCL was resuspended in Tris 50 mm, pH 7.5, and further purified by filtration on a Sephacryl S-200 column previously equilibrated with the same buffer. The elution was followed by UV absorption at 280 nm, and each fraction was analyzed by SDS-PAGE electrophoresis and N-glycosidase activity. The purest and most active fractions were concentrated on an Omega cell with a 10,000 molecular weight cutoff membrane (Pall Life Sciences) and stored at -20 °C.The N-terminal His-tagged RCL was overproduced and purified as follows. The Rcl gene cloned into pCR2.1 as a NdeI-BamHI fragment was subcloned into pET28a digested with the same restriction enzymes. The resulting pET28aRcl was used to transform strain Bli5. Culture conditions and induction were performed as described above. Frozen cells resuspended in 40 ml of extraction/wash buffer (50 mm Na2HPO4, NaH2PO4, 300 mm NaCl pH 7.0) were broken by two passages through a French press at 14,000 pounds/square inch. The lysate was centrifuged at 25,000 × g for 30 min at 4 °C. The supernatant was loaded on a column containing 6 ml of TALON resin (BD Biosciences) previously equilibrated with the same buffer. After washing, RCL was eluted with 150 mm imidazole. Fractions containing RCL were pooled and concentrated on an Omega cell 10 K membrane (Pall). The His-tagged RCL was further purified by gel filtration on a Sephacryl S-200 column. The purity was checked by SDS-PAGE electrophoresis and by measuring the specific activity. Purified His-tagged RCL was stored at -20 °C.RCL with Glu-105 Replaced by Ala (E105A Mutant) by Site-directed Mutagenesis—Oligonucleotides T7prom (5′-CGCGAAATTAATACGACTCACTATAGGGG-3′) and olinvE105A (5′-GCCCGGCCCAGCGCATAGCCAACACCCAAG-3′), T7term (5′-GGGGTTATGCTAGTTATTGCTCAGCGG-3′) and olE105A (5′-CTTGGGTGTTGGCTATGCGCTGGGCCGGGC-3′) were used in two separate PCRs with plasmid pET28aRcl as the DNA template. The parameters used were 1 cycle of 5 min at 95 °C, 25 cycles of 30 s at 95 °C, 30 s at 51.5 °C, and 1 min at 72 °C, and 1 cycle of 10 min at 72 °C. An aliquot (1/100 of the reaction) of each PCR was used as the DNA template in a third PCR with oligonucleotides T7prom and T7term. The parameters used were the same as described above. The PCR product was purified by using the QIAquick PCR purification kit (Qiagen) and then digested with NdeI and BamHI enzymes over 2 h at 37 °C and repurified. Each PCR product was ligated with plasmid pET28a digested with the same restriction enzymes. The ligation mixtures were used to transform strain DH5α. Plasmids with the correct sequence, pET28aRclE105A, were used to transform strain Bli5.Enzyme Activity Assays—The enzyme activity was determined either spectrophotometrically by following one of the reaction products, hypoxanthine or deoxyribose 5-phosphate, or by HPLC 3The abbreviations used are: HPLC, high pressure liquid chromatography; COG, clustering of orthologous groups. separation and UV detection of the released nucleobase and the remaining substrate.dIMP was used as a substrate, and the hypoxanthine released oxidized to uric acid by xanthine oxidase. The absorption increase at 290 nm was converted in enzymatic units using a millimolar absorbance coefficient of 12.0. One milliliter of the medium reaction thermostated at 37 °C contained 50 mm Tris-HCl, pH 7.5, 1 mm dIMP, 0.2 units of xanthine oxidase (Roche Applied Sciences) and 50–200 μg of purified RCL.d-Glyceraldehyde-3-phosphate, which is produced by the deoxyribose 5-phosphate aldolase from deoxyribose 5-phosphate, was coupled to the oxidation of NADH to NAD via the reactions catalyzed by triose phosphate isomerase and glycerol 3-phosphate dehydrogenase. The decrease in absorbance at 340 nm was followed on a Amersham Biosciences Ultrospec 3100 Pro spectrophotometer using a millimolar absorbance coefficient of 6.22. The reaction medium (1 ml final volume) contained 50 mm Tris acetate, pH 6.0, 0.1 mm NADH, and 1.5 units each of glycerol-3-phosphate dehydrogenase, triose phosphate isomerase (Roche Applied Sciences), deoxyribose-5-phosphate aldolase, 4Overproduction and purification of E. coli deoxyribose 5-phosphate aldolase. and 50–200 μg of purified RCL. One unit of enzyme activity corresponds to 1 μmol of product formed in 1 min at 37 °C and pH 6.0.HPLC assays were as described previously (14Kaminski P.A. J. Biol. Chem. 2002; 277: 14400-14407Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar). Hydrolase activities (dNMP → N + dR5P) were performed at 37 °C in 50 mm Tris acetate, pH 6.0, containing 1 mm dNMP and the appropriate amount of purified RCL. The reverse reaction (Gua + dR5P → dGMP) was performed at 37 °C in 50 mm Tris acetate, pH 6.0, containing 3 mm guanine, 3 mm deoxyribose 5-phosphate, and 200 μg of purified RCL. Deoxyribose 5-phosphate transferase reactions (dNMP + X → dXMP + N) were performed at 37 °C in Tris acetate, pH 6.0 (or 50 mm Tris-HCl, pH 7.5, or 50 mm citrate-sodium, pH 6.5), containing 1 mm dCMP or dGMP and 1 mm either adenine, cytosine, guanine, thymine, uracil, or hypoxanthine and 200 μg of purified RCL.The NdeI-HindIII fragment of pHSP234, which contains the Escherichia coli deoC gene (a kind gift of H. Sakamoto) was cloned into plasmid pET28a digested with the same restriction enzymes. The resulting plasmid, in strain Bli5, allows the expression of the deoxyribose 5-phosphate aldolase with an N-terminal His tag. Culture condition, induction, centrifugation, and purification on TALON resin were as described for His-RCL. Fractions containing deoxyribose 5-phosphate aldolase were dialyzed extensively against 10 mm Tris, pH 7.5, 50 mm NaCl, and 1 mm dithiothreitol concentrated in an Omega cell 10 K and kept frozen at -20 °C.Other Analytical Procedures—Protein concentration was determined using the Bradford assay kit from Bio-Rad. SDS-PAGE was performed as described by Laemmli (15Laemmli U.K. Nature. 1970; 227: 680-685Crossref PubMed Scopus (206057) Google Scholar). Mass spectrometry was performed by the PT3 proteomique of the Pasteur Institute as previously described (14Kaminski P.A. J. Biol. Chem. 2002; 277: 14400-14407Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar). Equilibrium sedimentation experiments were performed at 20 °C using a Beckman Optima XL-A analytical ultracentrifuge equipped with an An-60 Ti four-hole rotor. Samples (150 μl) at three protein concentrations (3, 10, and 30 μm), in 20 mm Tris-HCl, pH 7.5, 150 mm NaCl were run at six speeds (8, 10, 12, 14, 20, and 50 kilorevolutions/min). Five profiles were recorded after reaching equilibrium (12–18 h) at three wavelengths according to sample concentration (291, 280, and 231 nm, respectively). Partial specific volume v-bar of 0.713 ml/g was computed from the amino acid composition; solvent density = 1.004 g/ml and viscosity = 1.03 centipoise were set from tables. Data analysis was performed with the program Origin (Microcal).RESULTSPurification of RCL and Molecular Properties of the Recombinant Proteins—Both RCL and His-RCL were produced as soluble proteins, and their purity was estimated to be >95% by SDS-PAGE (Fig. 1). The molecular mass of RCL and His-RCL, according to appropriate markers (24–26 kDa), is higher than the deduced 18–20-kDa molecular mass. Electrospray ionization mass spectrometry of RCL indicated a molecular mass of 17,649.54 ± 0.92 Da and His-RCL of 19,812.06 ± 1.72 Da, which are very close to the sequence-deduced one (17,631.81 and 19,813.15 Da, respectively), with the initiating methionine being deleted. Equilibrium sedimentation experiments showed that, at 3 μm, His-RCL is mostly monomeric (free averaged molecular mass 22,603 Da). At 30 μm, His-RCL is mostly dimeric (free averaged molecular mass 40,522 Da). At 10 μm, His-RCL is at equilibrium between monomeric (20,440 Da) and dimeric (40,880 Da) states (Fig. 2). The dissociation constant (Kd) computed from the best fit with the 30 and the 10 μm data sets was 9.53 μm and 10.40 μm, with a mean value 10 ± 1 μm. No higher molecular mass oligomers were detected, indicating that the quaternary structure of RCL differs from that of N-deoxyribosyltransferase, which is a stable hexamer.FIGURE 2Determination of the molecular mass of His-RCL by analytical ultracentrifugation. Absorbance scans from ultracentrifugation experiments were reported as a function of radius to the rotor center. Only one scan per speed (10, 12, 14, and 20 kilorevolutions/min and per starting RCL concentration (10 μm) was indicated for clarity. The best overall fit over 1706 points (three scans, five speeds) was fitted with the continuous lines corresponding to the monomer-dimer equilibrium with a Kd = 10.40 μm and a variance of 4.76 10-4. Residual values were below 10-2 evenly spread over best fit lines.View Large Image Figure ViewerDownload Hi-res image Download (PPT)RCL at concentrations >1 mg/ml could be stored at -20 °C for at least 1 year without loss of activity. RCL is a heat-stable protein, as the temperature of half denaturation (Tm) was estimated to be ∼74 °C.The Rationale for Identifying the Catalytic Function of RCL—Examination of the homology of RCL with N-deoxyribosyltransferase from Lactobacilli revealed several interesting features (Fig. 3). Several amino acids that participate in the active site of Lactobacillus leichmannii N-deoxyribosyltransferase are conserved in RCL, such as the Glu-105, which is also involved in a hydrogen bond with the 3′-OH of the sugar of the deoxynucleoside (16Armstrong S.R. Cook W.J. Short S.A. Ealick S.E. Structure (Camb.). 1996; 4: 97-107Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar). Tyr-2, which stabilizes this bond, as well as Asp-75, involved in the binding of the base, are also conserved. Interestingly, the two amino acids, Asp-99 and Asn-172, involved in the binding of the 5′-OH of the sugar, are not conserved in RCL, being replaced by two Ser residues with smaller size (Fig. 3, inset). We hypothesized that the substrate recognized by RCL should be related to deoxynucleosides (substrate of N-deoxyribosyltransferase) or the corresponding phosphorylated compounds. Consequently, ∼50 ribonucleosides and deoxyribonucleosides, including their mono-, di-, and triphosphate derivatives, were incubated individually for several hours at 37 °C with pure RCL, and then the reaction products were analyzed by thin layer chromatography and later by HPLC (Fig. 4). When RCL was incubated with various deoxyribonucleoside 5′-monophosphates (and to a lesser extent with deoxyribonucleoside diphosphates), a constant reaction product was the corresponding free base. We deduced that RCL catalyzes the following hydrolytic reaction: deoxyribonucleoside 5′-monophosphate (dNMP) + H2O → free base (N) + deoxyribose 5-phosphate (dR5P). The existence of the two reaction products in stoichiometric amounts was demonstrated by using dIMP as a substrate and identifying enzymatically the end products, hypoxanthine and deoxyribose 5-phosphate, as described under “Experimental Procedures.” No deoxyribose 5-phosphate transfer was detected, whether dCMP or dGMP was the donor or any base was the acceptor. In addition, no dNMP was synthesized when RCL was incubated in the presence of deoxyribose 5-phosphate and guanine (data not shown). We concluded that RCL cleaves the N-glycosidic bond of deoxynucleoside 5′-monophosphate to liberate deoxyribose 5-phosphate and the free base and that this reaction is not reversible. Hence, we found a previously undescribed enzyme, deoxynucleoside 5′-monophosphate N-glycosidase, that is encoded by Rcl, a Myc target with tumorigenic potential.FIGURE 3Alignment of the nucleoside 2-deoxyribosyltransferase cluster of orthologs (COG 3613). Amino acids that participate in the catalytic active site of L. leichmannii are indicated in bold characters (GenBank™ accession codes gi_9279801, NTD L. helveticus; gi_14195395, Q9PR82 Ureaplasma parvum; gi_12723374, yejD Lactococcus lactis; gi_14026127, m116424 Mesorhizobium loti; gi_2688347, AAC68812 Borrelia burgdorferi; gi_4678672, CAB41051 Schizosaccharomyces pombe; gi_9945974, AAG03534 Pseudomonas aeruginosa PAO1; gi_9945975, AAG03534 P. aeruginosa PAO1; and gi_13423604, AAK24088 Caulobacter crescentus CB15). Structural model of the RCL substrate binding site based on the catalytic active site of L. leichmannii N-deoxyribosyltransferase. Amino acid changes in RCL are indicated by an arrow (amino acid numbers of L. leichmannii N-deoxyribosyltransferase have been modified to fit with the numbers of the alignment).View Large Image Figure ViewerDownload Hi-res image Download (PPT)FIGURE 4Formation of hypoxanthine following incubation of RCL with deoxyinosine 5′-monophosphate. A, HPLC chromatogram of deoxyinosine 5′-monophosphate (dIMP). B, HPLC chromatogram of hypoxanthine (Hx). C, HPLC chromatogram of deoxyinosine (dI). D, HPLC chromatogram of RCL assay products with deoxyinosine 5′-monophosphate as substrate. Retention times are indicated next to each peak. E and F correspond to the UV spectra from 210 to 400 nm of the hypoxanthine peak of B and of the product of the reaction from D, respectively (indicated by an asterisk).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Catalytic Properties of the Recombinant Proteins—With saturating concentrations of dGMP or dCMP, RCL showed an optimum pH value of ∼6.0. 50% of the maximal activity was still observed at pH 7.0 in the case of dCMP, whereas it was only 20% in the case of dGMP. In both cases at pH 8.0, only 10% of the enzyme activity remained. Several metals were tested for their ability to stimulate or inhibit the reaction, Ca2+, Mg2+, Zn2+, Na+, and K+. Only Zn2+ inhibited the reaction, whereas the other metals had no effect. Initial velocity experiments were carried out at variable concentrations of the six deoxynucleoside 5′-monophosphate: dAMP, dCMP, dGMP, dIMP, dTMP, and dUMP (Table 1). The kinetic parameters with dGMP indicate that RCL is a typical Michaelian enzyme with a Km value of 50 μm and a Vmax of 0.09 units·mg-1, which correspond to a kcat of 0.0268 s-1. Purine deoxynucleotides have a better affinity for RCL than pyrimidine deoxynucleotides. The Km value of RCL for dCMP (4 mm), dUMP (15 mm), and dTMP (>50 mm) are high as compared with dGMP (50 μm), dAMP (250 μm), and dIMP (450 μm). The kcat/Km measure of substrate efficiency also indicates a preference for purine deoxynucleotides. RCL cleaves dGMP 20 times more efficiently than dAMP and 40 times more than dIMP. kcat/Km and Km of RCL for dGMP (619 m-1·s-1 and 48 μm) are comparable with that reported for the related nucleotide hydrolase BlsM from Streptomyces griseochromogenes for dCMP (146 m-1·s-1 and 65 μm) (24Grochowski L.L. Zabriskie T.M. Chembiochem. 2006; 7: 957-964Crossref PubMed Scopus (16) Google Scholar).TABLE 1Kinetic parameters of His-RCL with different dNMPs as substrate Vmax and Km were obtained from double reciprocal plots of initial velocity measurements. For each dNMP, five different concentrations were used. ND, not determined Km >> [dTMP].NucleotidekcatKmkcat/Kms–1μmm–1 · s–1dGMP0.029748619dAMP0.006625026.4dIMP0.006645014.7dCMP0.023140005.8dUMP0.1581560010.1dTMPNDND<0.14 Open table in a new tab To better understand the catalytic mechanism of RCL, several compounds were tested as the substrate or inhibitor of the enzyme activity. The initial velocity of the reaction was measured either at a variable concentration of dGMP, both in the absence and presence of inhibitors, or at fixed a concentration of dGMP and variable concentrations of inhibitors, allowing the testing of the nature of the inhibition. The double reciprocal plot confirms that GMP and 6-methylthio-GMP are competitive inhibitors for dGMP with a Ki value of 20 and 10 μm, respectively. Thus, the presence of an OH at the 2′ position of the sugar has a critical influence. The position of the phosphate is also important, as 2′-deoxyguanosine 3′-monophosphate is neither a substrate nor an inhibitor of RCL. The presence of an oxo at position 8 of the base is sufficient to modify the recognition by RCL, as 8-oxo-dGMP is neither a substrate nor an inhibitor.Kinetic Parameters of RCL E105A Mutant—The similarity of the amino acids sequence and the similarity of reaction between RCL and N-deoxyribosyltransferase led us to investigate the catalytic mechanism. The Glu-105 was chosen for site-directed mutagenesis, because it is the active site nucleophile in L. leichmannii N-deoxyribosyltransferase (16Armstrong S.R. Cook W.J. Short S.A. Ealick S.E. Structure (Camb.). 1996; 4: 97-107Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar, 17Porter D.J. Merrill B.M. Short S.A. J. Biol. Chem. 1995; 270: 15551-15556Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar) and because of its conservation in the different N-deoxyribosyltransferase-like sequences (Fig. 3). The Glu-105 mutated to Ala in RCL (Table 2) has a profound effect on the Km value, which is enhanced by a factor of 170, whereas the Vmax value remains in the same order of magnitude. It was thus concluded that Glu-105 may be involved in the substrate binding but is not the catalytic amino acid as found in L. leichmannii N-deoxyribosyltransferase.TABLE 2Kinetic parameters of His-RCL (wild-type) and mutant His-RCL E105A with dGMP as substrate dGMP concentrations varied from 250 μm to 20 mm. Vmax and Km were obtained from double reciprocal plots of initial velocity measurements.EnzymekcatKmkcat/Km· s–1μmm–1 · s–1E105A variant0.017850003.6Wild-type0.029748619 Open table in a new tab DISCUSSIONWith increasing numbers of genome sequences available, functional prediction of open reading frames is a significant advance, but defining precise functions of novel open reading frames remains a challenge despite sequence homology to known functional domains. For example, the clustering of orthologous groups (COGs) that brought together comparative genomics and protein classification has allowed the automatic functional annotation of genes and proteins (18Tatusov R.L. Koonin E.V. Lipman D.J. Science. 1997; 278: 631-637Crossref PubMed Scopus (2732) Google Scholar). Orthologs most often have equivalent functions, and COG 3613 illustrates all of the proteins with a conserved domain with N-deoxyribosyltransferase. In COG 3613, only two crystal structures of N-deoxyribosyltransferases in the presence of different ligands were described (16Armstrong S.R. Cook W.J. Short S.A. Ealick S.E. Structure (Camb.). 1996; 4: 97-107Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar, 19Anand R. Kaminski P.A. Ealick S.E. Biochemistry. 2004; 43: 2384-2393Crossref PubMed Scopus (38) Google Scholar). These structures allowed the determination of the amino acid residues important in substrate binding and catalysis and also explained the substrate specificity. Knowing this, we reconsidered the 3613 COG by focusing our interest on RCL. RCL was chosen for several reasons: (i) it was the more distant protein in the COG, (ii) its function was unknown, (iii) it was only present in mammals, and (iv) the Rcl gene is a Myc target gene, which is up-regulated in human cancers and has tumorigenic potential. By combining the structural data obtained with L. leichmannii and Lactobacillus helveticus N-deoxyribosyltransferases and the sequence identities of RCL and N-deoxyribosyltransferases, we hypothesized that the two proteins may have related activities with different substrate specificities. The biochemical experiments performed with either pure native RCL or with a His-tagged RCL demonstrate that it codes for a deoxynucleoside 5′-monophosphate glycosidase, a previously undescribed activity. Indeed, N-glycosylhydrolases with a pyrimidine preference have been described in Neisseria meningitidis (20Jyssum S. APMIS. 1989; 97: 343-346Crossref PubMed Scopus (2) Google Scholar), Streptomyces virginiae (21Imada A. J. Gen. Appl. Microbiol. 1967; 13: 267-278Crossref Scopus (5) Google Scholar, 22Imada A. Kuno M. Igarasi S. J. Gen. Appl. Microbiol. 1967; 13: 255-265Crossref Scopus (5) Google Scholar), and S. griseochromogenes (23Cone M.C. Yin X. Grochowski L.L. Parker M.R. Zabriskie T.M. Chembiochem. 2003; 4: 821-828Crossref PubMed Scopus (52) Google Scholar, 24Grochowski L.L. Zabriskie T.M. Chembiochem. 2006; 7: 957-964Crossref PubMed Scopus (16) Google Scholar). On the other hand, ribosylhydrolases specific for inosine or adenosine 5′-monophosphate were also reported (25Kuninaka A. Koso Kagaku Shinpojiumu. 1957; 12: 65Google Scholar, 26Leung H.B. Schramm V.L. J. Biol. Chem. 1984; 259: 6972-6978Abstract Full Text PDF PubMed Google Scholar). None of them hydrolyze purine deoxynucleoside 5′-monophosphate. The RCL activity seems related to N-deoxyribosyltransferase, because in the absence of an acceptor base, L. leichmannii N-deoxyribosyltransferase catalyzes the hydrolysis of deoxynucleosides (27Smar M. Short S.A. Wolfenden R. Biochemistry. 1991; 30: 7908-7912Crossref PubMed Scopus (33) Google Scholar). L. leichmannii N-deoxyribosyltransferase is a hexamer in its native state, with one active site/subunit. A complete catalytic center requires the participation from a neighboring subunit, indicating that oligomerization is necessary for catalysis (16Armstrong S.R. Cook W.J. Short S.A. Ealick S.E. Structure (Camb.). 1996; 4: 97-107Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar). Molecular mass measurement shows that RCL is in a monomer-dimer equilibrium. It is notable that RCL (C6orf108) also dimerizes intracellularly in the yeast two-hybrid assay (5Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed" @default.
- W1995490361 created "2016-06-24" @default.
- W1995490361 creator A5035387431 @default.
- W1995490361 creator A5042387118 @default.
- W1995490361 creator A5071929559 @default.
- W1995490361 creator A5072642125 @default.
- W1995490361 date "2007-03-01" @default.
- W1995490361 modified "2023-10-01" @default.
- W1995490361 title "The c-Myc Target Gene Rcl (C6orf108) Encodes a Novel Enzyme, Deoxynucleoside 5′-monophosphate N-Glycosidase" @default.
- W1995490361 cites W1547703757 @default.
- W1995490361 cites W1569503749 @default.
- W1995490361 cites W1972780353 @default.
- W1995490361 cites W1976530842 @default.
- W1995490361 cites W1990453950 @default.
- W1995490361 cites W1997719793 @default.
- W1995490361 cites W2008069201 @default.
- W1995490361 cites W2023360935 @default.
- W1995490361 cites W2024247791 @default.
- W1995490361 cites W2025270159 @default.
- W1995490361 cites W2034315450 @default.
- W1995490361 cites W2045074917 @default.
- W1995490361 cites W2053689921 @default.
- W1995490361 cites W2056120923 @default.
- W1995490361 cites W2057751591 @default.
- W1995490361 cites W2059979716 @default.
- W1995490361 cites W2064772366 @default.
- W1995490361 cites W2080817494 @default.
- W1995490361 cites W2093937154 @default.
- W1995490361 cites W2100837269 @default.
- W1995490361 cites W2121963546 @default.
- W1995490361 cites W2164170982 @default.
- W1995490361 cites W2170155623 @default.
- W1995490361 cites W2172103753 @default.
- W1995490361 cites W2339953965 @default.
- W1995490361 cites W3213154483 @default.
- W1995490361 cites W4236865990 @default.
- W1995490361 doi "https://doi.org/10.1074/jbc.m610648200" @default.
- W1995490361 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17234634" @default.
- W1995490361 hasPublicationYear "2007" @default.
- W1995490361 type Work @default.
- W1995490361 sameAs 1995490361 @default.
- W1995490361 citedByCount "34" @default.
- W1995490361 countsByYear W19954903612013 @default.
- W1995490361 countsByYear W19954903612014 @default.
- W1995490361 countsByYear W19954903612015 @default.
- W1995490361 countsByYear W19954903612016 @default.
- W1995490361 countsByYear W19954903612017 @default.
- W1995490361 countsByYear W19954903612018 @default.
- W1995490361 countsByYear W19954903612019 @default.
- W1995490361 countsByYear W19954903612020 @default.
- W1995490361 countsByYear W19954903612021 @default.
- W1995490361 countsByYear W19954903612022 @default.
- W1995490361 countsByYear W19954903612023 @default.
- W1995490361 crossrefType "journal-article" @default.
- W1995490361 hasAuthorship W1995490361A5035387431 @default.
- W1995490361 hasAuthorship W1995490361A5042387118 @default.
- W1995490361 hasAuthorship W1995490361A5071929559 @default.
- W1995490361 hasAuthorship W1995490361A5072642125 @default.
- W1995490361 hasBestOaLocation W19954903611 @default.
- W1995490361 hasConcept C104317684 @default.
- W1995490361 hasConcept C153911025 @default.
- W1995490361 hasConcept C181199279 @default.
- W1995490361 hasConcept C185592680 @default.
- W1995490361 hasConcept C196032511 @default.
- W1995490361 hasConcept C55493867 @default.
- W1995490361 hasConcept C86803240 @default.
- W1995490361 hasConceptScore W1995490361C104317684 @default.
- W1995490361 hasConceptScore W1995490361C153911025 @default.
- W1995490361 hasConceptScore W1995490361C181199279 @default.
- W1995490361 hasConceptScore W1995490361C185592680 @default.
- W1995490361 hasConceptScore W1995490361C196032511 @default.
- W1995490361 hasConceptScore W1995490361C55493867 @default.
- W1995490361 hasConceptScore W1995490361C86803240 @default.
- W1995490361 hasIssue "11" @default.
- W1995490361 hasLocation W19954903611 @default.
- W1995490361 hasOpenAccess W1995490361 @default.
- W1995490361 hasPrimaryLocation W19954903611 @default.
- W1995490361 hasRelatedWork W1987826897 @default.
- W1995490361 hasRelatedWork W2009966535 @default.
- W1995490361 hasRelatedWork W2019988726 @default.
- W1995490361 hasRelatedWork W2082530227 @default.
- W1995490361 hasRelatedWork W2088063203 @default.
- W1995490361 hasRelatedWork W2171277769 @default.
- W1995490361 hasRelatedWork W2622571117 @default.
- W1995490361 hasRelatedWork W4236229680 @default.
- W1995490361 hasRelatedWork W4242974861 @default.
- W1995490361 hasRelatedWork W4380343563 @default.
- W1995490361 hasVolume "282" @default.
- W1995490361 isParatext "false" @default.
- W1995490361 isRetracted "false" @default.
- W1995490361 magId "1995490361" @default.
- W1995490361 workType "article" @default.